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S urgical intervention for esophageal cancer is site-specifically impacted by oral infection.  Oral 
pathogens could be causes of postoperative complica-
tions in esophagectomy including aspiration pneumo-
nia and surgical site infection.  Preoperative oral care is 
thus helpful to improve the prognosis of patients who 
are undergoing an esophagectomy.  For instance,  it is an 
effective and easy method to prevent postoperative 
pneumonia in such patients [1 , 2].  Occlusal support is 
also an important factor for accelerating recovery after 
surgery [3].  However,  it is difficult for patients with 
post-polio syndrome (PPS) to brush their teeth,  due to 
their progressive muscle weakness.  In such cases,  the 
support of medical personnel and family members is 
indispensable for the provision of proper oral hygiene.
Here,  we report a patient with esophageal cancer 
associated with PPS whose oral hygiene during neoad-
juvant chemotherapy was successfully improved by 
infection control by oral care provided by an interpro-
fessional collaboration,  and he was followed up without 
severe complications.
Case Report
An 81-year-old Japanese man visited an area hospi-
tal with the chief complaints of aphagia and abdominal 
discomfort.  He was diagnosed with lower esophageal 
cancer by upper gastrointestinal endoscopy.  He was 
advised to undergo an esophagectomy and was referred 
to the core hospital of Okayama Prefecture.  Contrast-
enhanced computed tomography and positron emission 
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tomography showed no metastatic tumor.  Radiation 
therapy was recommended by the core hospital because 
of surgical risks: his age,  respiratory dysfunction,  and 
muscular weakness.  He was subsequently referred to 
the Department of Gastroenterological Surgery,  
Okayama University Hospital,  as the core hospital 
could not perform radiation therapy.
He had hypertension,  an asymptomatic cerebral 
infarction,  hepatitis C virus (HCV) infection,  and PPS.  
He was being treated for the hypertension and asymp-
tomatic cerebral infarction,  but not the HCV infection 
or PPS.  His medication regimen included aspirin 
(81 mg),  dilazep hydrochloride hydrate (50 mg),  
nifedipine (20 mg),  imidapril hydrochloride (2.5 mg),  
mosapride citrate hydrate (5 mg),  and the traditional 
Japanese medicine rikkunshito (2.5 g).  He had quit 
smoking and drinking over 10 years earlier: he had had 
a smoking habit (15 cigarettes/day for 50 years) and 
drinking habit (22 g alcohol/day for 50 years).
The patient’s medical history of PPS was as follows.  
Since he suffered from febrile disease at the age of 
3 years,  he was aware of having a thin and weak left 
arm from the days of his earliest recollection.  As he 
could raise his arms,  he felt no inconvenience in daily 
life.  In his early 60s,  he felt difficulty in elevating his 
left arm,  although it did not hinder his ability to work.  
At the age of 61 years,  he retired and felt weakness of 
the left upper limb which developed gradually.  His right 
upper limb also gradually weakened,  and he felt incon-
venience when he lifted something.
At the age of 73 years,  he was suspected of having 
amyotrophic lateral sclerosis (ALS) and was admitted to 
the Department of Neurology,  Okayama University 
Hospital for further examination.  A neurological 
examination showed the dominant form of proximal 
muscular atrophy of the bilateral upper limbs and left 
lower limb,  increased tendon reflexes and pathological 
reflexes.  His extraocular movements were full and he 
did not present dysarthria,  dysphagia,  tongue atrophy,  
or fasciculation.  Laboratory data did not show creatine 
kinase elevation.  Magnetic resonance imaging (MRI) of 
the cervical spine did not show any abnormal findings 
of the ventral horn cells.  Needle electromyography 
showed no neurogenic change.  Although his cerebro-
spinal fluid was negative for poliovirus type 1-3 anti-
bodies,  he was clinically diagnosed with PPS.  ALS was 
not completely ruled out,  and cranial MRI revealed 
asymptomatic cerebral infarctions.   Antiplatelet drugs 
were then administered.  Thereafter,  the patient was 
followed up by the Department of Neurology,  Okayama 
University Hospital.
He was admitted to the Department of Gastro-
enterological Surgery,  Okayama University Hospital,  to 
receive neoadjuvant chemotherapy (NAC) for esopha-
geal cancer considering the radical esophagectomy at 
the age of 81 years.  The neurologist did not consider 
PPS as a short-term prognostic factor of the patient’s 
survival because of its very slow progression.  The NAC 
regimen consisted of fluorouracil (2,000 mg/day on 
days 1,  3,  and 4 and 4,000 mg/day on day 5) and cis-
platin (60 mg/day on day 1) (Fig. 1).
On day 1 of the NAC,  he was referred to the 
Perioperative Management Center (PERIO) for man-
agement during the preoperative period.  His body mass 
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Fig.  1 Changes in the involvement of each professional during the patientʼs neoadjuvant chemotherapy.  
index was 16.1 with a height of 159 cm and weight of 
40.8 kg.  He had developed PPS and had upper and 
lower limbs weakness.  He was able to walk while hold-
ing onto something.  He had been able to raise his 
hands only to hip level and had not been able to brush 
his teeth by himself.  However,  he was stubborn and 
irritable and unwilling to accept help.
On day 1 of the NAC,  the PERIO nurse consulted 
the dentist in the PERIO’s dental section about prevent-
ing oral complications during chemotherapy,  and the 
dentist attempted to address the patient’s dental prob-
lem.  However,  the patient refused treatment from any-
one other than his primary care dentist and did not give 
informed consent.  The PERIO dentist consulted with 
the patient’s primary care dentist,  and his primary care 
dentist advised the patient to consult the dentistry 
department in the hospital during his hospitalization.  
He finally agreed to receive oral care on day 6 of the 
NAC.
The number of white blood cells (WBC),  especially 
neutrophils (NE) gradually increased from day 1 of the 
NAC,  and he had a fever of > 37°C on days 1,  2,  and 5 
of the NAC (Fig. 2).  He had 6 residual teeth (33-43),  all 
of which were connected by a full metal crown.  He was 
using a maxillary complete denture and a mandibular 
partial denture.  His lips and oral cavity were dry.  He 
had thick white moss on his tongue and white spots on 
the vestibulum oris and buccal mucosa.  He also had an 
ulceration on the inside of the lower lip.  His oral and 
denture hygiene were poor.  He was clinically diagnosed 
as having oral mucositis Grade 3 according to the U.S.  
National Institutes of Health Common Terminology 
Criteria for Adverse Events version 3.0 [4],  oral pseu-
domembranous candidiasis,  and mouth dryness 
induced as a side effect of NAC.
Two days later,  Candida albicans (+++) and Candida 
glabrata (+++) were identified by a laboratory culture 
test on oral mucosal smear.  Although the patient 
refused swallowing testing by the otolaryngologist or 
dentist,  the neurologist had confirmed that he did not 
exhibit bulbar palsy (tongue atrophy),  dysarthria,  or 
dysphagia.  On the same day,  we developed an oral care 
plan based on our diagnosis and began to provide treat-
ment and care.
The dentist administered oral amphotericin B 
(Halizon Syrup® 100 mg/mL,  Fuji Pharma,  Tokyo) 
300 mg/day for 8 days,  and prescribed dimethyl iso-
propylazulene ointment (Azunol® Ointment 0.033%,  
Nippon Shinyaku,  Kyoto,  Japan) for the patient.  
Following the diagnosis and instructions by dentists,  
dental hygienists provided oral care for the patient 
including denture cleaning,  tooth cleaning of his 
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Fig.  2 Changes in the numbers of WBCs,  NEs,  body temperature (BT) and oral status during the neoadjuvant chemotherapy.  
remaining teeth with a toothbrush,  lip moisturizing 
with Vaseline,  and oral cavity moisturizing with a 
moisturizing mouth spray (Butler Gel Spray®,  Sunstar,  
Osaka,  Japan).  On day 12 of the NAC,  dental techni-
cians performed professional cleaning and denture pol-
ishing.  Ward nurses were instructed in proper oral care 
and performed daily oral care for the patient.  
The patient was emotionally unstable and had a ten-
dency of day-night reversal.  He did not have the mental 
capacity to give informed consent,  and he often shouted 
at medical personnel or was depressed.  It was difficult 
for him to discuss and make decisions about the treat-
ment strategy for esophageal cancer.  On day 14,  the 
attending doctor consulted a psychiatrist.  Although the 
patient had reduced mild cognitive and memory reten-
tion and decreased ability to lead to a conclusion when 
supplied with various types of information,  his orienta-
tion was not as badly impaired.  He was irritable when 
something happened contrary to his expectation,  but he 
calmed down when the situation was explained to his 
satisfaction.  He needed to be spoken to slowly in a loud 
voice because he had severe hearing loss.  He had no 
appreciable impaired consciousness or delirium.  The 
psychiatrist judged that he retained his decision-mak-
ing ability.  He was given trazodone hydrochloride 
(25 mg) and risperidone (1 mg) to improve the ten-
dency of day-night reversal.  The influence of PPS on his 
behavior was unclear.
After the dental intervention on day 6 of the NAC,  
the number of WBCs (especially NEs) gradually 
decreased,  and he had no longer had the > 37°C fever 
that had lasted for > 1 week.  On day 15,  the lip ulcer-
ation had healed and his dry mouth was ameliorated.  
His oral hygiene was improved,  and Candida was not 
detected in the oral cavity.  He was subsequently 
referred to another hospital to receive the second course 
of chemotherapy on day 17.  On day 15,  we had pre-
pared a dental referral that showed the ward nurse how 
to perform oral care.
After the second course of chemotherapy,  the 
patient decided not to undergo surgery when he was 
re-admitted to Okayama University Hospital.  We made 
dental referrals to an area hospital and his primary care 
dentist.  We informed the patient about the necessity of 
oral care and about consulting the primary care dentist 
and attending doctor in an area hospital.  We discussed 
our oral care management using a toothbrush,  sponge 
brush,  and moisturizing mouth spray,  the roles of ward 
nurses,  and clinical causes of Candida infection with the 
primary care dentist.
Informed consent for publication of the details of 
this case was obtained orally from the patient’s family.
Discussion
It is important to prevent the complication of pneu-
monia and provide perioperative nutrition for patients 
after esophagectomy.  The presence of pathogens in 
dental plaque is a risk factor for postoperative pneumo-
nia in esophageal cancer patients.  Postoperative pneu-
monia decreased from 32% to 9% and the frequency of 
postoperative pneumonia requiring tracheostomy 
decreased from 12% to 0% only by tooth brushing 
5 times a day [5].  Soutome et al.  investigated the effect 
of perioperative oral care in 539 esophageal cancer 
patients undergoing surgery,  and they concluded that 
perioperative oral care can reduce the risk of postoper-
ative pneumonia [2].
Oral infection can cause febrile neutropenia (FN) 
during chemotherapy [6].  In the present case,  from day 
1 to day 7 of the NAC,  the number of WBCs (especially 
NEs) gradually increased,  and the patient suffered from 
a fever > 37°C for 3 out of the first 5 days.  These find-
ings indicated that he had an infection.  On day 6 of the 
NAC,  we confirmed the presence of Candida as an oral 
pathogen and recognized the breakdown (i.e.,  oral 
mucositis) of the epithelial barrier as a route of patho-
gen entry.  After dental intervention on day 6 of the 
NAC,  the patient’s WBC and NE counts gradually 
decreased,  and he no longer had the > 37°C fever that 
had lasted > 1 week.  The oral care of the patient likely 
reduced the source of infection and fever.  In addition,  
the oral care might have reduced the risk of FN and 
antimicrobial agent use.
Occlusal support is another important factor affect-
ing nutritional support to improve the prognosis of 
patients after esophagectomy.  We have reported the 
case of an 82-year-old man who underwent esophagec-
tomy and gained body weight after receiving denture 
treatment; thus,  an appropriate prosthesis can contrib-
ute to perioperative nutrition support and lead to earlier 
recovery after surgery [3].  Moreover,  dysphagia is a 
concern in patients with PPS,  because their bulbar 
muscles often have clinical or subclinical signs of dys-
function [7].  Dysphagia suggests a slow,  progressive 
deterioration of bulbar neurons,  similar to that in the 
74 Arimasa et al. Acta Med.  Okayama　Vol.  73,  No.  1
muscles of the limbs [7].  Although our patient refused 
swallowing testing,  medical professionals including 
dentists and dental hygienists should prospectively fol-
low up swallowing function in patients with PPS.
In our patient’s case,  although he had a chief com-
plaint of aphagia at the first visit,  the neurologist con-
firmed that he did not exhibit bulbar palsy including 
dysphagia.  Aphagia might develop due to obstruction 
of the esophagus with cancer.  Although poliomyelitis 
has been almost completely eradicated in most industri-
alized countries including Japan,  PPS has emerged as a 
neuromuscular pathology in many survivors of the 
acute disease [8].  The most common symptoms are 
fatigue,  pain,  and new episodes of weakness thought to 
be related to a delayed deterioration of motor neuron 
function [9].  The effectiveness of pharmacological 
treatment and rehabilitation management in PPS is not 
yet established [10 , 11].  Patients with PPS need partic-
ular attention; for example,  understanding and con-
sideration of the disease in perioperative oral manage-
ment.  In our patient’s case,  oral care provided by an 
interprofessional collaboration proved to have a 
remarkable effect on the quality of life of this individual 
with progressive muscle weakness associated with PPS.
This oral care approach might be useful for patients 
with upper limb disability caused by neurological dis-
eases,  e.g.,  cerebrovascular disorders and sequelae of 
traumatic injuries.  Patients with PPS develop both 
physical symptoms,  including progressive muscle 
weakness,  and psychological symptoms,  such as 
chronic stress,  anxiety,  depression,  and compulsive 
type A behavior [12].  These symptoms not only cause 
marked distress but also prevent patients from making 
the necessary lifestyle changes to treat their illness [13].  
Psychological symptoms must be decreased so that 
patients can make necessary lifestyle changes and possi-
bly feel less lonely.  Patients need support from their 
family,  friends,  or medical personnel to accept lifestyle 
changes and treat their illness [13].
Our patient had hemiparesis of the upper limbs 
associated with sequelae of PPS,  and he could not per-
form oral care by himself.  He required support from his 
family,  friends,  or medical personnel to perform oral 
care.  However,  he had been stubborn and irritable and 
persisted in his idea of being self-sufficient.  His charac-
ter seemed to prevent us from providing preoperative 
oral care.  Initially,  he would not let anyone other than 
his primary care dentist treat him,  and he did not give 
us informed consent.  He had established a relationship 
of mutual trust with his primary care dentist over a long 
period of time.  He might have refused to consult 
another dentist other than his primary care dentist 
because of stubbornness as a characteristic of PPS.  
Moreover,  he had not understood the significance of 
consulting acute hospital dentists.
The primary care dentist informed the patient about 
the importance of perioperative dental management,  
and the patient then agreed to a dental intervention.  
Cooperation between the primary care dentist and the 
acute hospital dentist likely led to the successful out-
come.  It is noteworthy that the patient ultimately 
refused an esophagectomy and chose to stay home with 
his family and colleagues because polio survivors have a 
tendency to value social occupations and participation 
in family life [13].  In his case,  the interprofessional 
collaboration including his primary care dentist,  den-
tists of Okayama University,  dental hygienists,  dental 
technicians,  and ward nurses was critical (Fig. 3).  The 
further improvement of the patient’s oral health by 
interprofessional oral care performed as perioperative 
management and data-sharing with a primary care den-
tist would be useful for his continued care.
To our knowledge,  we have described the first case 
in which infection control by oral care proved by an 
interprofessional collaboration successfully improved 
the oral hygiene of a patient with esophageal cancer 
associated with PPS.  The patient was followed without 
severe complications during the NAC.  Further studies 
of larger populations are needed to confirm the efficacy 
of preoperative oral care in patients with cancers associ-
ated with PPS,  especially those with an upper limb 
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Fig.  3 The importance of interprofessional collaboration.  
disability caused by neurological disease or the sequelae 
of a traumatic injury.
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